Elixinol Wellness Limited (ASX:EXL)
Elixinol Global Limited (ASX:EXL) is a global leader in the hemp-derived CBD industry, researching, developing, marketing and selling Elixinol-branded, hemp-derived full and broad spectrum CBD products. Its operations are focused on the following markets:
Established in 2014 and based in Colorado, the group is an established market player with a strong brand reputation for quality and innovation. The group's focus is building its Elixinol consumer brand portfolio via its experienced manufacturing, R&D, sales and marketing teams across the US and Latin America.
Europe & UK
In the UK, Elixinol has an exclusive Trademark and Know-How Licensing Agreement with BRITISH CANNABIS, to manufacture, market and sell our CBD products.
The UK is Europes largest CBD market and BRITISH CANNABIS is a leading brand and manufacturer in the UK with access to all distribution channels.
As an Australian publicly listed company, the group's Global Executive office is based here with a focus on providing strategic oversight, unified planning, governance and investor relations on behalf of the group. Based in Sydney, Australia.
The group are also proud owners of one of Australias most established hemp foods brands with the award-winning Hemp Foods Australia. Located near Byron Bay, NSW, Hemp Foods Australia produces and distributes hemp-based food products.
Rest of World
Long established in South Africa, Japan and Mexico via 3rd party distribution and licensing agreements, the group is continuously expanding distribution of Elixinol branded hemp-derived CBD products through reputable distributors as key markets open.